Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $953.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.76% Avg Daily Range (30 D): $0.36 | 2.71% Avg Daily Range (90 D): $0.35 | 3.11% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.09M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 785 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $1.55M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.53M Avg Closing Trade (30 D): $1.86M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 122.83K     News Oct 15, 2025 @ 2:43 AM EyePoint Announces Pricing of Public Offering Source: Eyepoint Pharmaceuticals, Inc. Aug 26, 2025 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Eyepoint Pharmaceuticals, Inc. Jul 30, 2025 @ 11:00 AM EyePoint to Report Second Quarter 2025 Financial R... Source: Eyepoint Pharmaceuticals Jul 29, 2025 @ 11:00 AM EyePoint Completes Enrollment of Pivotal Phase 3 T... Source: Eyepoint Pharmaceuticals Jul 16, 2025 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Eyepoint Pharmaceuticals, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.85 $-.65 $-.65 Diluted EPS $-.85 $-.65 $-.65 Revenue $ 5.33M $ 24.45M $ 11.59M Gross Profit $ $ $ Net Income / Loss $ -59.43M $ -45.2M $ -41.4M Operating Income / Loss $ -62.23M $ -48.84M $ -45.24M Cost of Revenue $ $ $ Net Cash Flow $ -14.02M $ -14.55M $ 19.87M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4